|
Sign In to gain access to subscriptions and/or personal tools.
|
Fluctuations of antibody to ribosomal P proteins correlate with appearance and remission of nephritis in SLE
AL Martin
Arthritis/Immunology Program, Oklahoma Medical Research Foundation, Department of Medicine, Oklahoma University Health Sciences Center, 825 N.E. 13th Street, Oklahoma City, OK 73104, USA
M. Reichlin
Arthritis/Immunology Program, Oklahoma Medical Research Foundation, Department of Medicine, Oklahoma University Health Sciences Center, 825 N.E. 13th Street, Oklahoma City, OK 73104, USA
Antibodies to ribosomal P proteins are found in widely variable proportions (up to 42%) of patients with SLE depending on the ethnic background of the patient population. Neuropsychiatric disease was first recognized to have increased prevalence with anti-P and more recently liver and renal disease. We describe four patients with SLE and circumscribed episodes of nephritis of relatively short duration. In two patients, antibodies to ribosomal P protein were the only specificity detected at the time of appearance of active nephritis; and in the other two patients, the appearance and disappearance of anti-ribosomal P was simultaneously found with similar fluctuations in anti- dsDNA titers. Anti-ribosomal P antibodies were measured by Western blot and a P peptide-specific ELISA.
These data raise the possibility for a pathogenic role for anti-ribosomal P antibodies in lupus nephritis.
Key Words: anti-ribosomal P nephritis
Lupus, Vol. 5, No. 1,
22-29 (1996)
DOI: 10.1177/096120339600500106

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Haddouk, S. Marzouk, M. Jallouli, H. Fourati, M. Frigui, Y. B. H. Hmida, F. Koubaa, W. Sellami, S. Baklouti, J. Hachicha, et al.
Clinical and diagnostic value of ribosomal P autoantibodies in systemic lupus erythematosus
Rheumatology,
August 1, 2009;
48(8):
953 - 957.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Mahler, K. Kessenbrock, M. Szmyrka, Y. Takasaki, I. Garcia-De La Torre, Y. Shoenfeld, F. Hiepe, C. Shun-le, C. A. von Muhlen, H. Locht, et al.
International Multicenter Evaluation of Autoantibodies to Ribosomal P Proteins
Clin. Vaccine Immunol.,
January 1, 2006;
13(1):
77 - 83.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-H. Sun, S.-J. Tang, M.-L. Lin, Y.-S. Wang, G.-H. Sun, and W.-T. Liu
Monoclonal antibodies against human ribosomal P proteins penetrate into living cells and cause apoptosis of Jurkat T cells in culture
Rheumatology,
July 1, 2001;
40(7):
750 - 756.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S Zampieri, W Degen, A Ghiradello, A Doria, and W J van Venrooij
Dephosphorylation of autoantigenic ribosomal P proteins during Fas-L induced apoptosis: a possible trigger for the development of the autoimmune response in patients with systemic lupus erythematosus
Ann Rheum Dis,
January 1, 2001;
60(1):
72 - 76.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. Frampton, S. Moriya, J. D. Pearson, D. A. Isenberg, F. J. Ward, T. A. Smith, A. Panayiotou, N. A. Staines, and J. J. Murphy
Identification of candidate endothelial cell autoantigens in systemic lupus erythematosus using a molecular cloning strategy: a role for ribosomal P protein P0 as an endothelial cell autoantigen
Rheumatology,
October 1, 2000;
39(10):
1114 - 1120.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Chatterjee, S. Singh, R. Sohoni, N. J. Singh, A. Vaidya, C. Long, and S. Sharma
Antibodies against Ribosomal Phosphoprotein P0 of Plasmodium falciparum Protect Mice against Challenge with Plasmodium yoelii
Infect. Immun.,
July 1, 2000;
68(7):
4312 - 4318.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|